These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 35612697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues.
    Ades A, Carvalho JP, Graziani SR, Amancio RF, Souen JS, Pinotti JA, Maranhão RC.
    Gynecol Oncol; 2001 Jul; 82(1):84-7. PubMed ID: 11426966
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers.
    Dias ML, Carvalho JP, Rodrigues DG, Graziani SR, Maranhão RC.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):105-11. PubMed ID: 16699792
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.
    Kretzer IF, Maria DA, Maranhão RC.
    Cell Oncol (Dordr); 2012 Dec; 35(6):451-60. PubMed ID: 23055341
    [Abstract] [Full Text] [Related]

  • 8. Deposition of free cholesterol in the blood vessels of patients with coronary artery disease: a possible novel mechanism for atherogenesis.
    Couto RD, Dallan LA, Lisboa LA, Mesquita CH, Vinagre CG, Maranhão RC.
    Lipids; 2007 May; 42(5):411-8. PubMed ID: 17443358
    [Abstract] [Full Text] [Related]

  • 9. Nanotechnology for the treatment of deep endometriosis: uptake of lipid core nanoparticles by LDL receptors in endometriotic foci.
    Bedin A, Maranhão RC, Tavares ER, Carvalho PO, Baracat EC, Podgaec S.
    Clinics (Sao Paulo); 2019 May; 74():e989. PubMed ID: 31291391
    [Abstract] [Full Text] [Related]

  • 10. Tissue Uptake Mechanisms Involved in the Clearance of Non-Protein Nanoparticles that Mimic LDL Composition: A Study with Knockout and Transgenic Mice.
    Daminelli EN, Fotakis P, Mesquita CH, Maranhão RC, Zannis VI.
    Lipids; 2017 Dec; 52(12):991-998. PubMed ID: 29094255
    [Abstract] [Full Text] [Related]

  • 11. Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE.
    Pinheiro KV, Hungria VT, Ficker ES, Valduga CJ, Mesquita CH, Maranhão RC.
    Cancer Chemother Pharmacol; 2006 May; 57(5):624-30. PubMed ID: 16133527
    [Abstract] [Full Text] [Related]

  • 12. An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.
    Lourenço-Filho DD, Maranhão RC, Méndez-Contreras CA, Tavares ER, Freitas FR, Stolf NA.
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1522-8. PubMed ID: 21458008
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.
    Maranhão RC, Vital CG, Tavoni TM, Graziani SR.
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1217-1226. PubMed ID: 28042707
    [Abstract] [Full Text] [Related]

  • 14. Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil.
    Alanazi FK, Haq N, Radwan AA, Alsarra IA, Shakeel F.
    Pharm Dev Technol; 2015 May; 20(3):266-70. PubMed ID: 24266739
    [Abstract] [Full Text] [Related]

  • 15. Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients.
    Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, Couto RD, Schreier S, Buzaid AC.
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):487-98. PubMed ID: 12107554
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit.
    Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira MD.
    Atherosclerosis; 2008 Apr; 197(2):959-66. PubMed ID: 18289548
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
    Hungria VT, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC.
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458
    [Abstract] [Full Text] [Related]

  • 18. Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide.
    Valduga CJ, Fernandes DC, Lo Prete AC, Azevedo CH, Rodrigues DG, Maranhão RC.
    J Pharm Pharmacol; 2003 Dec; 55(12):1615-22. PubMed ID: 14738586
    [Abstract] [Full Text] [Related]

  • 19. Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
    Kretzer IF, Maria DA, Guido MC, Contente TC, Maranhão RC.
    Int J Nanomedicine; 2016 Dec; 11():885-904. PubMed ID: 27022257
    [Abstract] [Full Text] [Related]

  • 20. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.
    Mello SB, Tavares ER, Bulgarelli A, Bonfá E, Maranhão RC.
    Int J Nanomedicine; 2013 Dec; 8():443-9. PubMed ID: 23439784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.